A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS

BACKGROUND: The treatment strategies for Myelodysplastic Syndromes (MDS) are usually based on the risk stratification system. However, few risk signatures which integrate the revised international prognostic scoring system (IPSS-R) with gene mutations can be easily applied in the real world. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Siyu, Xia, Jingya, Tian, Yulu, Zi, Jie, Ge, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866647/
https://www.ncbi.nlm.nih.gov/pubmed/33549060
http://dx.doi.org/10.1186/s12885-021-07864-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866647/
https://www.ncbi.nlm.nih.gov/pubmed/33549060
http://dx.doi.org/10.1186/s12885-021-07864-y

Ejemplares similares